vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Qnity Electronics, Inc. (Q). Click either name above to swap in a different company.

Qnity Electronics, Inc. is the larger business by last-quarter revenue ($1.3B vs $749.2M, roughly 1.8× CLOVER HEALTH INVESTMENTS, CORP.). Qnity Electronics, Inc. runs the higher net margin — 12.3% vs 3.6%, a 8.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 10.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CLOV vs Q — Head-to-Head

Bigger by revenue
Q
Q
1.8× larger
Q
$1.3B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+51.5% gap
CLOV
62.0%
10.5%
Q
Higher net margin
Q
Q
8.7% more per $
Q
12.3%
3.6%
CLOV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
Q
Q
Revenue
$749.2M
$1.3B
Net Profit
$27.3M
$162.0M
Gross Margin
47.0%
Operating Margin
3.6%
Net Margin
3.6%
12.3%
Revenue YoY
62.0%
10.5%
Net Profit YoY
48.6%
EPS (diluted)
$0.05
$0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
Q
Q
Q1 26
$749.2M
$1.3B
Q4 25
$487.7M
Q3 25
$496.6M
$1.3B
Q2 25
$477.6M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
Net Profit
CLOV
CLOV
Q
Q
Q1 26
$27.3M
$162.0M
Q4 25
$-49.3M
Q3 25
$-24.4M
$211.0M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
$199.0M
Q2 24
$7.4M
Gross Margin
CLOV
CLOV
Q
Q
Q1 26
47.0%
Q4 25
Q3 25
45.1%
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
47.0%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
Q
Q
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
21.3%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
21.8%
Q2 24
2.0%
Net Margin
CLOV
CLOV
Q
Q
Q1 26
3.6%
12.3%
Q4 25
-10.1%
Q3 25
-4.9%
16.5%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
17.3%
Q2 24
2.1%
EPS (diluted)
CLOV
CLOV
Q
Q
Q1 26
$0.05
$0.72
Q4 25
Q3 25
$1.01
Q2 25
Q1 25
Q4 24
Q3 24
$0.95
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
Q
Q
Cash + ST InvestmentsLiquidity on hand
$177.6M
$857.0M
Total DebtLower is stronger
$4.0B
Stockholders' EquityBook value
$339.4M
$7.5B
Total Assets
$697.7M
$14.1B
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
Q
Q
Q1 26
$177.6M
$857.0M
Q4 25
$78.3M
Q3 25
$128.0M
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
Q
Q
Q1 26
$4.0B
Q4 25
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
Q
Q
Q1 26
$339.4M
$7.5B
Q4 25
$308.7M
Q3 25
$340.9M
$9.1B
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
$11.1B
Q2 24
$324.9M
Total Assets
CLOV
CLOV
Q
Q
Q1 26
$697.7M
$14.1B
Q4 25
$541.0M
Q3 25
$559.7M
$12.5B
Q2 25
$575.0M
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Debt / Equity
CLOV
CLOV
Q
Q
Q1 26
0.54×
Q4 25
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons